These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11099872)
1. Lipid effects, effectiveness and acceptability of tibolone versus transdermic 17 beta-estradiol for hormonal replacement therapy in women with surgical menopause. Mendoza N; Suárez AM; Alamo F; Bartual E; Vergara F; Herruzo A Maturitas; 2000 Nov; 37(1):37-43. PubMed ID: 11099872 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Castelo-Branco C; Vicente JJ; Figueras F; Sanjuan A; Martínez de Osaba MJ; Casals E; Pons F; Balasch J; Vanrell JA Maturitas; 2000 Feb; 34(2):161-8. PubMed ID: 10714911 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women. Dansuk R; Unal O; Karageyim Y; Esim E; Turan C Gynecol Endocrinol; 2004 May; 18(5):233-9. PubMed ID: 15346658 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of two hormone replacement therapy regimens on safety and efficacy variables. Siseles NO; Halperin H; Benencia HJ; Berg G; Pilnik S; Mesch V; Arrighi B; Wikinski RW Maturitas; 1995 Apr; 21(3):201-10. PubMed ID: 7616869 [TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal estradiol gel and oral tibolone on health-related quality of life after surgical menopause. Bhattacharya SM; Jha A Int J Gynaecol Obstet; 2010 Sep; 110(3):213-6. PubMed ID: 20570264 [TBL] [Abstract][Full Text] [Related]
6. Prevention of post-oophorectomy bone loss with Tibolone. Lyritis GP; Karpathios S; Basdekis K; Grigoriou O; Katostaras T; Paspati I; Stamatopoulos T; Siampalioti G; Lyritis PG Maturitas; 1995 Nov; 22(3):247-53. PubMed ID: 8746883 [TBL] [Abstract][Full Text] [Related]
7. Prospective, randomised study with three HRT regimens in postmenopausal women with an intact uterus. Mendoza N; Pisón JA; Fernández M; Sánchez MC; Malde J; Miranda JA Maturitas; 2002 Apr; 41(4):289-98. PubMed ID: 12034516 [TBL] [Abstract][Full Text] [Related]
8. The effect of tibolone versus 17beta-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study. Somunkiran A; Erel CT; Demirci F; Senturk ML Maturitas; 2007 Jan; 56(1):61-8. PubMed ID: 16831525 [TBL] [Abstract][Full Text] [Related]
9. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Godsland IF Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901 [TBL] [Abstract][Full Text] [Related]
10. Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis. Fedele L; Bianchi S; Raffaelli R; Zanconato G Maturitas; 1999 Aug; 32(3):189-93. PubMed ID: 10515676 [TBL] [Abstract][Full Text] [Related]
11. Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. Nathorst-Böös J; Hammar M Maturitas; 1997 Jan; 26(1):15-20. PubMed ID: 9032742 [TBL] [Abstract][Full Text] [Related]
12. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women. Hudita D; Posea C; Ceausu I; Rusu M Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586 [TBL] [Abstract][Full Text] [Related]
14. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women. Cayan F; Dilek U; Pata O; Dilek S J Sex Med; 2008 Jan; 5(1):132-8. PubMed ID: 17961145 [TBL] [Abstract][Full Text] [Related]
17. Tibolone versus four estrogen replacement therapy protocols and plasma lipid levels in postmenopausal women. Cetinkaya MB; Alper T; Kokcu A; Yanik FF; Malatyalioglu E Int J Gynaecol Obstet; 2002 Oct; 79(1):17-23. PubMed ID: 12399086 [TBL] [Abstract][Full Text] [Related]
18. Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women. Genazzani AD; Gamba O; Nappi L; Volpe A; Petraglia F Maturitas; 1997 Sep; 28(1):27-33. PubMed ID: 9391992 [TBL] [Abstract][Full Text] [Related]
19. Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low-dose estrogen or tibolone treatment: a comparison. Botsis D; Kassanos D; Kalogirou D; Antoniou G; Vitoratos N; Karakitsos P Maturitas; 1997 Jan; 26(1):57-62. PubMed ID: 9032748 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study. Botsis D; Kassanos D; Kalogirou D; Antoniou G; Karakitsos P; Zourlas PA Maturitas; 1997 May; 27(1):77-83. PubMed ID: 9158081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]